| Nome |
# |
|
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis, file e39773b2-1c08-35a3-e053-3a05fe0aac26
|
2.179
|
|
The Glutamatergic Neurotransmission in the Central Nervous System, file e39773b1-bad1-35a3-e053-3a05fe0aac26
|
1.824
|
|
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE, file e39773b2-2fc0-35a3-e053-3a05fe0aac26
|
908
|
|
A flow cytometric approach in the characterization of actively induced EAE in Lewis rat, file e39773b2-2458-35a3-e053-3a05fe0aac26
|
703
|
|
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale., file e39773b2-230e-35a3-e053-3a05fe0aac26
|
655
|
|
Metabolomics assessment in a mice model ofoxaliplatin-induced peripheral neurotoxicity, file ec02ea51-afa2-456a-97d8-3b2dfe941d4c
|
484
|
|
Ex-vivo study of extracorporeal photochemotherapy effects on immune system: early experience in healthy controls and a multiple sclerosis patient., file e39773b2-2d1c-35a3-e053-3a05fe0aac26
|
454
|
|
Changes in neuroactive steroids in experimental autoimmune encephalomyelitis, file e39773b2-2e06-35a3-e053-3a05fe0aac26
|
442
|
|
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model, file e39773b2-1c52-35a3-e053-3a05fe0aac26
|
429
|
|
Granulocytes in actively induced Lewis rat EAE, file e39773b4-b98e-35a3-e053-3a05fe0aac26
|
428
|
|
Extracorporeal photochemotherapy: early ex-vivo experience on healthy controls and a multiple sclerosis patient to investigate a new potential cell therapy., file e39773b2-264c-35a3-e053-3a05fe0aac26
|
425
|
|
Acid sphingomyelinase knockout mice: peripheral nervous system alterations, file e39773b2-1c49-35a3-e053-3a05fe0aac26
|
419
|
|
Effect of proteasome inhibition on the central and peripheral nervous system, file e39773b2-2bac-35a3-e053-3a05fe0aac26
|
410
|
|
Enhanced brain targeting of engineered solid lipid nanoparticles, file e39773b2-75b9-35a3-e053-3a05fe0aac26
|
372
|
|
Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models, file e39773b2-1978-35a3-e053-3a05fe0aac26
|
339
|
|
MSCs effect on Dark Agouti rats affected by chronic EAE, file e39773b1-f4c1-35a3-e053-3a05fe0aac26
|
278
|
|
A new device to study ex-vivo the effects of extracorporeal photochemotherapy on the immune system: early experience in healthy controls and a multiple sclerosis patient., file e39773b2-1dbc-35a3-e053-3a05fe0aac26
|
241
|
|
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis., file e39773b4-dab6-35a3-e053-3a05fe0aac26
|
220
|
|
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain, file e39773b2-0bd4-35a3-e053-3a05fe0aac26
|
169
|
|
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier, file e39773b9-5f39-35a3-e053-3a05fe0aac26
|
160
|
|
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy, file e39773b7-237b-35a3-e053-3a05fe0aac26
|
159
|
|
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy, file e39773b2-1b32-35a3-e053-3a05fe0aac26
|
152
|
|
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery, file e39773b7-aa1b-35a3-e053-3a05fe0aac26
|
133
|
|
Management of oxaliplatin-induced peripheral sensory neuropathy, file e39773b6-896b-35a3-e053-3a05fe0aac26
|
132
|
|
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy, file e39773b7-d119-35a3-e053-3a05fe0aac26
|
130
|
|
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy, file e39773b7-438e-35a3-e053-3a05fe0aac26
|
128
|
|
Different strains of mice are differently susceptible to cisplatin-induced painful peripheral neuropathy (cipn): role of pharmacogenomics?, file e39773b2-1a13-35a3-e053-3a05fe0aac26
|
114
|
|
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy, file e39773b8-c109-35a3-e053-3a05fe0aac26
|
101
|
|
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine, file e39773b7-0979-35a3-e053-3a05fe0aac26
|
100
|
|
Reversal of bortezomib-induced neurotoxicity by suvecaltamide, a selective T-type ca-channel modulator, in preclinical models, file e39773b8-0628-35a3-e053-3a05fe0aac26
|
98
|
|
The Italian neuromuscular registry: A coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage, file e39773b7-0d34-35a3-e053-3a05fe0aac26
|
94
|
|
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity, file e39773b6-d43d-35a3-e053-3a05fe0aac26
|
92
|
|
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats, file e39773b7-32a4-35a3-e053-3a05fe0aac26
|
92
|
|
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer, file e39773b7-0ea5-35a3-e053-3a05fe0aac26
|
90
|
|
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats, file e39773b2-164e-35a3-e053-3a05fe0aac26
|
87
|
|
How can neuroplasticity be utilized to improve neuropathy symptoms?, file e39773b7-98a2-35a3-e053-3a05fe0aac26
|
86
|
|
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose, file e39773b2-26d7-35a3-e053-3a05fe0aac26
|
85
|
|
Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth, file e39773b7-0ea7-35a3-e053-3a05fe0aac26
|
83
|
|
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings, file e39773b7-954b-35a3-e053-3a05fe0aac26
|
81
|
|
Neurotoxicity induced by cisplatin, taxol and bortezomib in immunocompetent cd1 mice and immunodeficient nude mice, file e39773b2-1acf-35a3-e053-3a05fe0aac26
|
79
|
|
Enhanced brain targeting of engineered solid lipid nanoparticles, file e39773b2-b542-35a3-e053-3a05fe0aac26
|
72
|
|
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa, file e39773b5-f126-35a3-e053-3a05fe0aac26
|
72
|
|
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review, file 12afb626-c2fe-4066-af4b-298c164ea39f
|
68
|
|
Oxaliplatin induces pH acidification in dorsal root ganglia neurons, file e39773b7-0b54-35a3-e053-3a05fe0aac26
|
68
|
|
Electrophysiological, behavioral and molecular characterization of the neuropathic pain in bortezomib-induced peripheral neuropathy., file e39773b2-1769-35a3-e053-3a05fe0aac26
|
66
|
|
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats, file e39773b6-b52b-35a3-e053-3a05fe0aac26
|
66
|
|
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights, file e39773b6-b1ab-35a3-e053-3a05fe0aac26
|
64
|
|
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents, file e39773b6-e1e0-35a3-e053-3a05fe0aac26
|
64
|
|
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity, file e39773b6-b81b-35a3-e053-3a05fe0aac26
|
63
|
|
Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy, file e39773b6-ee40-35a3-e053-3a05fe0aac26
|
63
|
|
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP, file e39773b8-6264-35a3-e053-3a05fe0aac26
|
63
|
|
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets, file e39773b7-3296-35a3-e053-3a05fe0aac26
|
61
|
|
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity, file e39773b6-f6cc-35a3-e053-3a05fe0aac26
|
60
|
|
Alterations of gut microbiota composition in post-finasteride patients: a pilot study, file e39773b7-097e-35a3-e053-3a05fe0aac26
|
60
|
|
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models, file e39773b7-3f4d-35a3-e053-3a05fe0aac26
|
60
|
|
Lack of sterol regulatory element binding factor-1c imposes glial fatty acid utilization leading to peripheral neuropathy, file e39773b7-1450-35a3-e053-3a05fe0aac26
|
58
|
|
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification, file e39773b6-dab3-35a3-e053-3a05fe0aac26
|
57
|
|
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect, file e39773b7-6a81-35a3-e053-3a05fe0aac26
|
57
|
|
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values, file e39773b8-4078-35a3-e053-3a05fe0aac26
|
57
|
|
Regional variation of Guillain-Barré syndrome, file e39773b6-f0df-35a3-e053-3a05fe0aac26
|
56
|
|
INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED
PERIPHERAL NEUROPATHY, file f0470f39-c76f-4099-a822-b18862e0d9ab
|
56
|
|
Peripheral neuropathy induced by chronic administration of cisplatin, taxol and bortezomib in several murine models, file e39773b2-167c-35a3-e053-3a05fe0aac26
|
55
|
|
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells, file 9598eb7a-20a1-4f5e-b244-dc5ebf890110
|
54
|
|
Platinum-induced neurotoxicity and preventive strategies: Past, present, and future, file e39773b7-3a3d-35a3-e053-3a05fe0aac26
|
54
|
|
Evaluation of the neuroprotective effect of acetyl-l-carnitine in myeloma-bearing mice treated with bortezomib, file e39773b2-1924-35a3-e053-3a05fe0aac26
|
53
|
|
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505), file e39773b7-0db1-35a3-e053-3a05fe0aac26
|
53
|
|
A phosphotyrosine switch regulates organic cation transporters, file e39773b7-2146-35a3-e053-3a05fe0aac26
|
53
|
|
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse, file e39773b2-1679-35a3-e053-3a05fe0aac26
|
52
|
|
Enhanced brain targeting of engineered solid lipid nanoparticles, file e39773b2-6e24-35a3-e053-3a05fe0aac26
|
52
|
|
Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: A pilot study, file e39773b7-2766-35a3-e053-3a05fe0aac26
|
52
|
|
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats, file e39773b2-145c-35a3-e053-3a05fe0aac26
|
51
|
|
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE, file e39773b7-0303-35a3-e053-3a05fe0aac26
|
51
|
|
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial, file e39773b7-9314-35a3-e053-3a05fe0aac26
|
50
|
|
The Italian law on body donation: A position paper of the Italian College of Anatomists, file e39773b7-d9a8-35a3-e053-3a05fe0aac26
|
50
|
|
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice., file e39773b2-19fe-35a3-e053-3a05fe0aac26
|
48
|
|
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity, file e39773b7-3497-35a3-e053-3a05fe0aac26
|
47
|
|
The Italian multiple sclerosis register, file e39773b7-8614-35a3-e053-3a05fe0aac26
|
47
|
|
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy, file e39773b6-d441-35a3-e053-3a05fe0aac26
|
46
|
|
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review, file cf55b30d-c91d-4977-9b06-c1764e29045c
|
45
|
|
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS, file e39773b2-196d-35a3-e053-3a05fe0aac26
|
45
|
|
Characterization of the painful peripheral neuropathy induced by oxaliplatin-based chemotherapy in balb-c mice, file e39773b2-1d7d-35a3-e053-3a05fe0aac26
|
45
|
|
Microbeam radiation therapy - Grid therapy and beyond: A clinical perspective, file e39773b7-2145-35a3-e053-3a05fe0aac26
|
45
|
|
Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer, file e39773b6-e8c6-35a3-e053-3a05fe0aac26
|
44
|
|
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis, file e39773b2-1635-35a3-e053-3a05fe0aac26
|
43
|
|
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: An international observational study, file e39773b8-0178-35a3-e053-3a05fe0aac26
|
43
|
|
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons, file e39773b9-6666-35a3-e053-3a05fe0aac26
|
43
|
|
Neurological Complications of Conventional and Novel Anticancer Treatments, file 68a488a3-71a7-4eb4-b769-98f4b9c755bb
|
42
|
|
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY, file e39773b2-1969-35a3-e053-3a05fe0aac26
|
40
|
|
Neurochemical characterization of bortezomib-induced peripheral neuropathy: expression of trpv1, cgrp and substance p in the rat drg and dorsal horn of spinal cord, file e39773b2-1b34-35a3-e053-3a05fe0aac26
|
40
|
|
The lipogenic regulator Sterol Regulatory Element Binding Factor-1c is required to maintain peripheral nerve structure and function, file e39773b7-8dd2-35a3-e053-3a05fe0aac26
|
40
|
|
Characterization of new murine models of peripheral neuropathy induced by chronic administration of antineoplastic drugs., file e39773b2-1583-35a3-e053-3a05fe0aac26
|
39
|
|
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level, file e39773b2-13dd-35a3-e053-3a05fe0aac26
|
38
|
|
CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS, file e39773b2-150a-35a3-e053-3a05fe0aac26
|
35
|
|
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models, file e39773b2-1956-35a3-e053-3a05fe0aac26
|
32
|
|
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells, file 6a404231-388a-4723-9e98-4bfa79a71ea1
|
31
|
|
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy, file 63ca8f63-04b5-4e18-890b-d764f6f0c735
|
30
|
|
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain, file e39773b2-0be4-35a3-e053-3a05fe0aac26
|
29
|
|
Transient receptor potential vanilloid type 1 (TRPV1) and neuropeptides in the dorsal root ganglia and spinal cord in a rat model of Bortezomib-induced neuropathy, file e39773b2-1d69-35a3-e053-3a05fe0aac26
|
26
|
|
TUBULIN: A TARGET FOR SEVERAL ANTINEOPLASTIC DRUGS, file e39773b2-1424-35a3-e053-3a05fe0aac26
|
25
|
|
Evaluation of in vitro antitumoral activity and neurotoxicity of a Hibiscus Sabdariffa ethyl acetate fraction against human multiple myeloma cells, file e39773b4-b7f4-35a3-e053-3a05fe0aac26
|
25
|
| Totale |
16.659 |
